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ABSTRACT
Berberine is an isoquinoline alkaloid isolated from goldenthread, Coptidis Rhizoma 
and shown to have many biological and pharmacological effects. We previously re-
ported that berberine promotes cell survival and differentiation of neural stem cells. To 
examine whether berberine has survival promoting effect on damaged neuronal cells, 
we generated a cellular model under oxidative stress and an neonatal animal model of 
degenerating brain disease by injecting MK-801. MK801, a noncompetitive antagonist 
of N-methyl-d-aspartate (NMDA) receptors, acts as a neurotoxin in developing rats by 
inhibiting NMDA receptors and induce neuronal cell death. We found that the survival 
rate of the SH-SY5Y cells under oxidative stress was increased by 287% and 344%, 
when treated with 1.5 and 3.0μg/ml berberine, respectively. In the developing rats in-
jected by MK801, we observed that TUNEL positive apoptotic cells were outspread in 
entire brain. The cell death was decreased more than 3 fold in the brains of the 
MK-801-induced neurodegenerative animal model when berberine was treated to the 
model animals. This suggests that berberine promotes activity dependent cell survival 
mediated by NMDA receptor because berberine is known to activate neurons by 
blocking K
＋ current or lowering the threshold of the action potential. Taken together, 
berberine has neuroprotective effect on damaged neurons and neurodegenerating 
brains of neonatal animal model induced by MK-801 administration.
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INTRODUCTION
    Berberine  is  an  isoquinoline  alkaloid  and  often 
isolated  from  goldenthread,  Coptidis  Rhizoma,  and 
goldenseal,  Hydrastis  Canadensis  (Mirska  et  al., 
1972).  Previous  reports  have  shown  that  berberine 
has  several  pharmacological  and  biological  pro-
perties  including  antibiotic  (Mirska  et  al.,  1972), 
anti-inflammatory  (Marinova  et  al.,  2000;  Zhou  and 
Mineshita,  2000;  Yoo  et  al.,  2008)  and  anti-hypo-
lipidemic  (Kong  et  al.,  2004)  effects.  It  has  been 
reported that berberine attenuated neuronal damage 
in  ischemia/reperfusion  model  (Yoo  et  al.,  2006), 
and  in  autoimmune  encephalomyelitis  model  mice 
(Ma et al., 2010). Berberine showed neuroprotective 
effects  on  stroke  models  (Zhou  et  al.,  2008)  and 
focal  cerebral  ischemia  injury  (Xiao  et  al.,  2007). 
Previously,  we  reported  that  berberine  enhances 
neuronal  cell  survival  and  differentiation  in  hip-
pocampal  precursor  cells  and  neurons  in  the  rat 
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showed that berberine has an antioxidant action on 
corpus  cavenosum  smooth  muscle  cells  in  which 
oxidative  stress  were  induced  (Tan  et  al.,  2007). 
    To  examine  whether  berberine  has  survival  pro-
moting  effect  on  damaged  neuronal  cells,  we  ge-
nerated  a  degenerating  brain  disease  model  by 
injecting  neurotoxin  to  developing  rats.  MK-801 
[(5S,10R)-(＋)-5-methyl-10,11-dihydro-5H-dibenzo 
[a,d]  cyclohepten-5,10-imine  maleate,  dizocilpine]  is 
a noncompetitive antagonist of N-methyl-d-aspartate 
(NMDA)  receptors  (Wong  et  al.,  1986;  Javitt  and 
Zukin,  1991).  In  rodents,  MK-801  induces  a  be-
havioral  syndrome,  including  hyperlocomotion,  head 
weaving,  body  rolling,  and  ataxia  (Clineschmidt  et 
al.,  1982;  Tricklebank  et  al.,  1989;  Liljequist  et  al., 
1991),  which  represents  certain  aspects  of  schi-
zophrenia (Carlsson and Carlsson, 1990; Tiedtke et 
al.,  1990).  MK-801  is  also  known  to  induce  neu-
rodegeneration  of  hippocampal  CA1  and  entorhinal 
cortex  in  adult  animals  when  administrated  with 
high concentrations (10 mg/kg) of MK-801 (Wohrl et 
al.,  2007). 
    In  the  developing  rat  brain,  blockade  of  NMDA 
receptors  with  low  dose  of  MK801  during  late  fetal 
or  early  neonatal  life  triggers  widespread  apoptotic 
neurodegeneration  (12∼26%  of  cells)  (Ikonomidou 
et  al.,  1999).  This  suggests  the  transient  blockade 
of  NMDA  receptors  can  trigger  neuronal  cell  death 
in  the  immature  mammalian  brain  during  a  period 
of  rapid  axonal  growth  and  synaptogenesis,  and 
the  excitatory  neurotransmitter  glutamate,  acting  at 
NMDA  receptors,  controls  neuronal  survival.  Thus, 
Neurodegenerative MK-801 model of the developing 
rat  has  relevance  to  human  neurodevelopmental 
disorders involving postnatal exposure to drugs that 
block NMDA receptors such as pediatric anesthesia.
    Berberine  has  been  reported  to  increase  action 
potential  by  inhibition  of  voltage  dependent  potas-
sium  current  in  cat  ventricular  myocytes  (Huang, 
1990;  Sanchez-Chapula, 1996)  and  in  human mye-
loma  cells  (Wu  et  al.,  1998)  and  hepatocytes 
(Wang  et  al.,  2003).  Berberine  suppresses  dopa-
mine-induced  potassium  current  and  acetylcholine 
induced  potassium  current  in  acutely  dissociated 
CA1  pyramidal  neurons  (Wu  and  Jin,  1996;  1997). 
It is also suggested that berberine contributes to its 
blockades  of  potassium  currents  in  damaged  is-
chemic  brain  (Wang  et  al.,  2004).  This  leads  us  a 
question  whether  berberine  reduces  cell  death  on 
damaged  brain  of  developing  animal  model  rats 
induced by MK801. We  tested first the cell  survival 
promoting effect of berberine on SH-SY5Y neuronal 
cells  damaged  by  oxidative  stress  and  then 
examined  whether  berberine  blocks  cell  death  in 
vivo  developing  rat  model  induced  by  MK801. 
MATERIALS  AND  METHODS
Cell  culture
    Human  neuroblastoma  SH-SY5Y  cells  were  ac-
quired  from  ATCC.  As  previously  described,  SH- 
SY5Y cells were  maintained in Dulbecco’s modified 
Eagle’s  medium  (DMEM,  Invitrogen,  USA)  supple-
mented with 10% fetal bovine serum (FBS, Thermo, 
USA),  penicillin,  and  streptomycin  at  37
oC  (Heo  et 
al.,  2009).  For  the  SH-SY5Y  cells  0.1  mM  MEM 
non-essential  amino  acids  were  also  added.
Cell  viability  assay
    To  estimate  damage  of  cultured  cells  which 
caused  by  oxidative  stress,  we  performed  cell 
viability  assay  by  using  3-(4,5-dimethylthiazol-2-yl)- 
2,5-diphenyltetrazolium  bromide  (MTT,  Sigma-Ald-
rich,  USA).  SH-SY5Y  cells  were  seeded  at  a 
density of 7.5×10
3 cells in 96-well plate. Cells were 
treated with different concentration (0.25, 1.5, 3 and 
3.5μg/ml)  of  berberine  chloride  (Sigma-  Aldrich, 
USA).  4  mg/ml  of  MTT  tetrazolium  salt  was  added 
to each well and incubated for 4 hrs at 37
oC. After 
that,  100μl  of  solubilization  buffer  was  added  and 
then  incubated  for  24  hrs.  Result  were  measured 
by  ELISA  (Molecular  devices,  USA). 
Neonatal  animal  model  of  neuronal  cell  da-
maged  by  MK-801  injection
    Sprague  Dawley  rats  were  maintained  under 
standard housing conditions and a 12：12 light/dark 
cycle  (lights  on  at  06:30  AM)  with  free  access  to 
water  and  standard  food.  All  procedures  were 
performed  in  accordance  with  the  guidelines  of  the 
National  Institutes  of  Health  (NIH)  for  the  care  and 
use  of  laboratory  animals.  The  neonatal  rat  model 
of  developmental  disorder  was  constructed  as 
described  previously  (Ikonomidou  et  al.,  1999).  In 
brief,  postnatal  day  7  animals  were  randomly  di-
vided  into  a  control  group  (n=3)  and  a  group 142 Taehwan  Lee,  et  al.
Fig.  1.  Neuronal  cell  viability  was  improved  by  berberine  treat-
ment  in  cultured  SH-SY5Y  cells  under  oxidative  stress  induced 
by  hydrogen  peroxide  (H2O2).  SH-SY5Y  cells  were  pretreated 
with berberine (BER, 0.25, 1.5, 3 and 3.5μg/ml) 3 hours before 
H2O2  treatment  (150μM,  30  min)  in  chemically  defined  N2 
media.  SH-SY5Y  cells  treated  with  retinoic  acid  (RA,  5μM) 
represents  positive  control.  Cell  survival  was  measured  by  MTT 
assay  and  cell  viability  was  normalized  to  H2O2  added  control. 
Data  represents  means±standard  error  measures.  **p＜0.001 
compared  with  the  control,  one-way  ANOVA.
injected with MK-801 (dizocilpine 0.5 mg/kg of body 
weight;  Sigma,  St.  Louis,  MO,  USA),  NMDA  re-
ceptor  antagonist  (n=3).  MK-801  was  dissolved  in 
0.9%  saline  and  injected  intraperitoneally  (i.p.). 
Control rats received saline only. Berberine chloride 
were  dissolved  in  0.9%  saline  and  injected  intra-
peritoneally  every  24  hours  for  5  days  and  control 
rats received saline again.  The  degenerating  brains 
were  examined  at  5
th  day  by  TUNEL  (terminal 
deoxynucleotidyl  transferase-mediated  dUTP  nick- 
end  labeling)  assay  to  detect  apoptotic  cells.
TUNEL  assay
    To  visualize  nuclei  with  DNA  cleavage,  brain 
were  cut  using  a  vibratome  and  brain  slices  were 
incubated  with  0.1%  Triton  X-100  in  0.1%  sodium 
citrate  (permeable  solution)  for  2  min  on  4
oC. 
Subsequently  brain  slices  were  incubated  with 
nucleotide-labeling  mixture  and  terminal  deoxynu-
cleotidyl  transferase  (Roche,  Switzerland)  for  1  hr 
at  37
oC  to  catalytically  add  peroxidase-labeled 
digoxigenin  nucleotide  to  DNA  fragments.  Nuclei 
displaying  DNA  cleavage  had  a  dark  brown  ap-
pearance.  We  counted  the  number  of  TUNEL  po-
sitive  cells  in  the  microscophic  fields  (n=12).
RESULTS
    In the previous study, we have demonstrated that 
berberine  promotes  cell  survival  in  neuronal  stem 
cells.  To  investigate  the  cell  survival  effect  of  ber-
berine  on  damaged  neurons,  we  examined  ber-
berine  effect  in  the  cultured  cellular  model  under 
the  condition  of  oxidative  stress.  SH-SY5Y  cells 
were exposed under oxidative stress by adding 150
μM  H2O2  for  30  min  after  being  pretreated  with 
0.25∼3.5μg/ml of berberine for 3 hrs. When serum 
is  removed  from  media  and  changed  to  chemically 
defined  N2  media  survival  of  SH-SY5Y  cells  are 
reduced  and  initiates  neurite  outgrowth.  As  shown 
in Fig. 1, the survival rate of the groups treated by 
1.5  and  3.0μg/ml  berberine  was  increased  by 
287%  and  344%,  respectively  compared  to  the  N2 
media  control.  However,  the  survival  rate  of  the 
groups  treated  by  3.5μg/ml  berberine  was  re-
duced  to  about  200%,  the  similar  level  of  0.25
μg/ml  concentration,  suggesting  that  higher  con-
centration  is  not  more  effective. 
    To determine the protective effect of berberine in 
the  damaged  neuronal  cells  of  developing  animal 
model,  we  generated  neonatal  animal  model  of 
degenerating  brain  by  injecting  intraperitoneally  to 
postnatal  day  7  aged  rats  0.5  mg/kg  of  MK-801, 
which  is  a  non-competitive  antagonist  of  the  N- 
methyl-d-aspartate  (NMDA)  receptor,  as  described 
previously  (Ikonomidou  et  al.,  1999).  As  described 
previously, we also observed changes of cell shape 
including  intracytoplasmatic  vacuoles  in  the  cortex 
of  rats  treated  with  a  low  dose  of  MK-801  (0.5 
mg/kg body weight) when stained with haematoxylin 
and eosin (Olney et al., 1989; Fix et al., 1994). We 
intraperitoneally  injected  20  mg/kg  of  berberine,  or 
vehicle,  to  the  model  animals  for  5  days.  After 
sacrificing  the  animals,  the  brain  slices  were  pre-
pared  to  perform  TUNEL  assay  (Fig.  2).  TUNEL 
positive  apoptotic  cells  were  outspread  in  entire 
brain  of  the  developing  rats  injected  by  MK801.
    However,  the  cell  death  was  decreased  more 
than  3  fold  in  the  brains  of  berberine  admini-
strated  animals.  The  number  of  TUNEL  positive 
cells  of  the  control  group  were  27×10
2  cells  per 
microscophic  field  (×200;  Vehicle  n=3,  BER  n=3), 
on  the  other  hand,  the  number  of  TUNEL  positive 
cells  of  the  berberine  group  were  7×10
2  cells  per 
microscophic  field  (×200;  Vehicle  n=3,  BER  n=3).Berberine  Effect  on  Damaged  Neonatal  Rat  Brain 143
Fig.  2.  Berberine  reduced  cell  death  in  the  developing  neonatal  rats  damaged  by  MK-801.  (A)  A  schematic  diagram  represents 
experimental  schedule.  MK-801  (0.5  mg/kg;  i.p.)  injected  at  postnatal  day  7.  (B)  TUNEL  positive  apoptotic  cells  were  reduced  by  BER 
injection  (20  mg/kg,  5  days).  (C)  Quantification  graph  indicates  number  of  TUNEL  positive  cells  in  the  microscopic  field  (×200;  Vehicle 
n=3,  BER  n=3).  Data  indicates  means  ±standard  error  measures.  *p＜0.01  compared  with  the  vehicle  injected  group,  one-way  ANOVA.
DISCUSSION
    Recently,  berberine  is  shown  to  enhance  cell 
survival by reducing reactive oxygen species (ROS), 
the release of cytochrome c and apoptosis-inducing 
factors  (AIFs)  in  PC12  cells  damaged  by  oxygen- 
glucose  deprivation  (Zhou  et  al.,  2008).  In  this 
report  we  have  demonstrated  that  survival  pro-
moting  effect  of  berberine  in  both  damaged    neu-
ronal cell model and degenerating brain of neonatal 
animal  model.  SH-SY5Y  cell  culture  model  induced 
by adding H2O2 are well established as a damaged 
neuronal  cell  model  for  ischemic  studies.  Ischemic 
conditions induce apoptosis by generating excessive 
ROS  (Zhang  et  al.,  2009).  We  found  berberine  in-
creases  cell  viability  of  SH-SY5Y  under  oxidative 
stress  about  3  fold.  This  result  implies  the  anti- 
apoptotic  effect  of  berberine  under  oxidative  stress 
condition.
    We  also  found  the  anti-apoptotic  effect  of  ber-
berine  in  the  MK801  induced  animal  model.  To 
make  the  model  animals,  we  injected  low  dose  of 
MK-801  into  the  developing  postnatal  day  7  rats, 
and MK801 induced TUNEL positive apoptotic cells 
were found in entire brain of the developing rats as 
Ikonomidou  and  his  colleges  previously  described 
(1999).  Although  half  life  of  MK-801,  NMDA  re-
ceptor  anatagoist  is  only  for  a  few  hours  (Vezzani 
et  al.,  1989),  neuronal  apoptosis  in  the  immature 
mammalian  brain  can  be  triggered  by  the  transient 
blockade  of  glutamate  NMDA  receptors.  This  is 
probably  caused  by  mechanism  of  activity  de-
pendant cell survival which is induced by release of 
neurotransmitter, glutamate and activation of NMDA 
receptor  on  target  cells.  Activation  of  the  NMDA 
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releases retrograde signal which is required for cell 
survival  of  presynaptic  neurons.  During  a  period  of 
rapid  brain  growth  or  synaptogenesis  period,  such 
target  derived  survival  signals  from  post-synaptic 
neurons  regulate  strengthening  of  the  synapses  as 
well  as  cell  survival  of  pre  and  post-synaptic  neu-
rons,  thereby  forming  neuronal  networks.  Blockage 
of  NMDA  receptors  inhibits  to  produce  target  de-
rived  survival  factors  and  cause  apoptosis  of  pre 
and  post-synaptic  neurons.
    When  berberine  was  injected  to  the  MK801 
model  rats,  apoptotic  cells  were  decreased  more 
than  3  fold.  Other  researcher  group  also  reported 
neuroprotective  action  of  berberine  in  organotypic 
hippocampal  slice  culture  induced  by  oxygen  and 
glucose  deprivation  (Cui  et  al.,  2009).  Berberine 
has  also  been  reported  to  block  transient  outward 
potassium  current  (IA)  and  delayed  rectifier  potas-
sium  current  (IK)  in  acutely  isolated  CA1  pyramidal 
neurons of rat hippocampus by using the whole-cell 
patch-clamp  techniques.  These  biological  functions 
were suggested as a protective mechanism against 
ischemic  brain  damage  (Wang  et  al.,  2004).  In  our 
animal model of neonatal brain damaged by NMDA 
receptor  antagonist,  MK801,  berberine  probably  sti-
mulates  cell  survival  of  neuronal  cells  expressing 
NMDA  receptors  by  blocking  potassium  current  or 
lowering  the  threshold  of  the  action  potential.  This 
may  elevate  synaptic  depolarization  and  activate 
channel  opening  of  NMDA  receptors  and  calcium 
influx.
    Thus,  we  suggest  that  these  anti-apoptotic  effect 
of  berberine  on  the  neurodegenerating  brain  of 
neonatal animal model caused by promoting activity 
dependent  cell  survival.   
    In the immature mammalian brain during a period 
of  rapid  synaptogenesis,  the  transient  blockade  of 
glutamate  NMDA  receptors,  or  the  excessive  ac-
tivation  of  gamma-aminobutyric  acid  (GABA(A))  re-
ceptors  trigger  neuronal  apoptosis.  Apoptogenic 
agents  include  anesthetics  and  drugs  of  abuse 
including  phencyclidine,  ketamine,  and  ethanol.  In 
humans,  the  brain  growth  period  are  between  the 
sixth  month  of  pregnancy  and  the  third  year  after 
birth.  Agents  used  in  pediatric  and  obstetrical 
medicine  for  purposes  of  sedation,  anesthesia,  and 
seizure management may cause apoptotic neuronal 
degeneration  in  the  developing  human  brain  such 
as  dysmorphogenic  changes  in  the  fetal  brain  and 
consequent  neurobehavioral  disturbances.   
    In  conclusion,  berberine  has  cell  survival  pro-
moting  effect  on  damaged  neuronal  cells  under 
oxidative  stress  and  degenerating  brains  of  de-
veloping  animal  model  induced  by  MK801. 
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